Use of remifentanil as a sedative agent in critically ill adult patients: a meta‐analysis
Authors:
- 6 November 2009
- journal article
- review article
- Published by Wiley in Anaesthesia
- Vol. 64 (12) , 1342-1352
Abstract
Summary: This meta‐analysis examined the benefits of using remifentanil as a sedative agent in critically ill patients. A total of 11 randomised controlled trials, comparing remifentanil with another opioid or hypnotic agent in 1067 critically ill adult patients, were identified from the Cochrane controlled trials register and EMBASE and MEDLINE databases, and subjected to meta‐analysis. Remifentanil was associated with a reduction in the time to tracheal extubation after cessation of sedation (weighted‐mean‐difference −2.04 h (95% CI −0.39 to −3.69 h); p = 0.02). Remifentanil was, however, not associated with a significant reduction in mortality (relative risk 1.01 (95% CI 0.67–1.52); p = 0.96), duration of mechanical ventilation, length of intensive care unit stay, and risk of agitation (relative risk 1.08 (95% CI 0.64–1.82); p = 0.77) when compared to an alternative sedative or analgesic agent. The current evidence does not support the routine use of remifentanil as a sedative agent in critically ill adult patients.Keywords
This publication has 21 references indexed in Scilit:
- Altering Intensive Care Sedation Paradigms to Improve Patient OutcomesCritical Care Clinics, 2009
- Arrêt journalier de la sédation en réanimation chez l'insuffisant rénal : rémifentanil–midazolam versus fentanyl–midazolamAnnales Françaises d'Anesthésie et de Réanimation, 2007
- Remifentanil versus Morphine Analgesia and Sedation for Mechanically Ventilated Critically Ill PatientsAnesthesiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Statistics notes: Interaction 3: How to examine heterogeneity: Table 1BMJ, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Measured Context-sensitive Half-times of Remifentanil and AlfentanilAnesthesiology, 1995
- Remifentanil Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 1995
- Pharmacokinetics of Remifentanil (GI87084B) and Its Major Metabolite (GI90291) in Patients Undergoing Elective Inpatient SurgeryAnesthesiology, 1993
- The Pharmacokinetics of the New Short-acting Opioid Remifentanil (GI87084B) in Healthy Adult Male VolunteersAnesthesiology, 1993